MatsukiyoCocokara & Co.

3088

JP3869010003

Drug Retailers

Market Closed - Japan Exchange Other stock markets 07:00:00 28/05/2024 BST			5-day change	1st Jan Change
2,214 ^JPY	-1.47%		-5.53%	-11.33%

05-13	Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 10, 2024.	CI
05-13	MatsukiyoCocokara & Co.'s Equity Buyback announced on May 10, 2024, has closed with 415,000 shares, representing 0.1% for ¥953.26 million.	CI

Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 10, 2024.

May 13, 2024 at 02:00 am

From May 10, 2024 to May 13, 2024, the company has repurchased 415,000 shares, representing 0.1% for ¥953.26 million. With this, the company has completed the repurchase of 415,000 shares, representing 0.1% for ¥953.26 million under the buyback announced on May 10, 2024.

Latest news about MatsukiyoCocokara & Co.

Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 10, 2024.	05-13	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on May 10, 2024, has closed with 415,000 shares, representing 0.1% for ¥953.26 million.	05-12	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 420,000 shares, representing 0.1% for ¥964.74 million.	05-10	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	05-09	CI
Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- 2nd Update	02-28	DJ
Aeon Co. Plans to Merge Japan Drugstore Unit Welcia With Rival Tsuruha -- Update	02-28	DJ
Aeon Co. Weighs Merger of Drugstore Unit Welcia With Rival Tsuruha -- 3rd Update	02-26	DJ
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on November 14, 2023.	11-15	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on November 14, 2023, has closed with 715,200 shares, representing 0.17% for ¥1,941.77 million.	11-14	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 800,000 shares, representing 0.19% for ¥2,172 million.	11-14	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	11-13	CI
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on August 10, 2023.	14/08/23	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on August 10, 2023, has closed with 200,000 shares, representing 0.14% for ¥1,742 million.	13/08/23	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 220,000 shares, representing 0.16% for ¥1,936 million.	10/08/23	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	09/08/23	CI
MatsukiyoCocokara & Co. Reports Earnings Results for the Full Year Ended March 31, 2023	12/05/23	CI
Morgan Stanley Adjusts MatsukiyoCocokara's Price Target to 8,300 Yen From 6,600 Yen, Keeps at Overweight	11/05/23	MT
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on February 14, 2023.	15/02/23	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on February 14, 2023, has closed with 1,150,000 shares, representing 0.82% for ¥7,555.50 million.	14/02/23	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 1,250,000 shares, representing 0.89% for ¥8,500 million.	14/02/23	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	13/02/23	CI
Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on November 14, 2022.	15/11/22	CI
MatsukiyoCocokara & Co.'s Equity Buyback announced on November 14, 2022, has closed with 204,000 shares, representing 0.14% for ¥1,071 million.	14/11/22	CI
MatsukiyoCocokara & Co. announces an Equity Buyback for 230,000 shares, representing 0.16% for ¥1,500 million.	14/11/22	CI
MatsukiyoCocokara & Co. authorizes a Buyback Plan.	13/11/22	CI

Chart MatsukiyoCocokara & Co.

Duration

Period

More charts

Company Profile

MatsukiyoCocokara & Co, formerly Matsumotokiyoshi Holdings Co Ltd, is engaged in retail business, wholesale business and management support business. Retail business is engaged in operating chain stores of drugstores and insurance pharmacies, opening and operating insurance dispensing pharmacies, dispatching pharmacists and others. Wholesale business purchases and sells products handled by group companies and business partners that engage in retail business, develops franchise businesses, and supplies products to franchisees. The Management Support segment is involved in the management of group companies and contracting of indirect business, planning and development of private brand products, asset management and operation, the construction and maintenance of stores, as well as the operation of non-life and life insurance agency business.

Sector

Drug Retailers

Calendar

08/08/2024 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for MatsukiyoCocokara & Co.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2,214 JPY

Average target price

2,945 JPY

Spread / Average Target

+33.02%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

	1st Jan change	Capi.
MATSUKIYOCOCOKARA & CO.	-11.33%	5.97B
WALGREENS BOOTS ALLIANCE, INC.	-41.10%	13.83B
JD HEALTH INTERNATIONAL INC.	-26.34%	11.5B
YIFENG PHARMACY CHAIN CO., LTD.	+14.31%	6.41B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED	-20.28%	6.32B
CORPORATIVO FRAGUA, S.A.B. DE C.V.	+72.00%	5B
NAHDI MEDICAL COMPANY	-3.36%	4.63B
CLICKS GROUP LIMITED	-6.07%	3.96B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD.	-18.47%	3.24B
WELCIA HOLDINGS CO., LTD.	-12.71%	2.85B

Other Drug Retailers

MatsukiyoCocokara & Co.

Equities

3088

JP3869010003

Drug Retailers

Tranche Update on MatsukiyoCocokara & Co.'s Equity Buyback Plan announced on May 10, 2024.

EPS Revisions